Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqCM - Delayed Quote USD

OSR Holdings, Inc. (OSRH)

Compare
4.2200
+0.7700
+(22.32%)
At close: February 21 at 4:00:01 PM EST
3.9700
-0.25
(-5.92%)
After hours: February 21 at 7:58:26 PM EST
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2022
Total Revenue
4,453,551.0600
--
Cost of Revenue
3,266,142.2160
--
Gross Profit
1,187,408.8440
--
Operating Expense
15,930,194.2720
--
Operating Income
-14,742,785.4280
--
Net Non Operating Interest Income Expense
-464,689.6860
--
Other Income Expense
-524,436.7190
--
Pretax Income
-15,732,365.4190
--
Tax Provision
-2,130,704.9110
--
Net Income Common Stockholders
-13,601,660.5080
--
Diluted NI Available to Com Stockholders
-13,601,660.5080
--
Basic EPS
-770.04
76.14
Diluted EPS
-770.04
76.14
Basic Average Shares
17,663.4930
17,663.4930
Diluted Average Shares
17,663.4930
17,663.4930
Total Operating Income as Reported
-14,742,785.4280
--
Rent Expense Supplemental
29,620.3530
--
Total Expenses
19,196,336.4880
--
Net Income from Continuing & Discontinued Operation
-13,601,660.5080
--
Normalized Income
-13,140,918.4645
--
Interest Income
24,992.4320
--
Interest Expense
489,682.1180
--
Net Interest Income
-464,689.6860
--
EBIT
-15,242,683.3010
--
EBITDA
-2,723,670.6630
--
Reconciled Cost of Revenue
3,243,313.4680
--
Reconciled Depreciation
12,519,012.6380
--
Net Income from Continuing Operation Net Minority Interest
-13,601,660.5080
--
Total Unusual Items Excluding Goodwill
-532,917.4470
--
Total Unusual Items
-532,917.4470
--
Normalized EBITDA
-2,190,753.2160
--
Tax Rate for Calcs
0.0001
--
Tax Effect of Unusual Items
-72,175.4035
--
12/31/2022 - 3/21/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FGEN FibroGen, Inc.
0.7059
-8.61%
 
SLDB Solid Biosciences Inc.
5.78
-3.67%
 
ADTX Aditxt, Inc.
0.0915
-22.98%
 
MBRX Moleculin Biotech, Inc.
1.2800
-8.57%
 
NKGN NKGen Biotech, Inc.
0.5695
+27.12%
 
APTO Aptose Biosciences Inc.
0.1621
-14.68%
 
EDIT Editas Medicine, Inc.
1.9200
-6.80%
 
IVVD Invivyd, Inc.
1.7700
+46.28%
 
BPTH Bio-Path Holdings, Inc.
0.2100
0.00%
 
OCEA Ocean Biomedical, Inc.
0.1266
-9.12%